{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-136157","form_type":"8-K","ticker":"AVD","cik":"0000005981","company_name":"AMERICAN VANGUARD CORP","filed_at":"2024-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.670222+00:00","generated_at":"2026-06-02T04:21:24.934178+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"American Vanguard Q1 net sales up 8% to $135M; adjusted EBITDA up 35% to $15.5M; guides FY adjusted EBITDA $60-70M","bullets":["Net sales $135M (+8% YoY); diluted EPS $0.06 vs $0.07; net income $1.6M vs $1.9M.","Adjusted EBITDA $15.5M (+35%); operating income $6.1M (+87%); transformation program targets $15M annualized EBITDA by 2026.","FY guidance: net sales growth 6-9%, adjusted EBITDA $60-70M.","Voluntarily suspended Dacthal herbicide sales pending EPA label resolution; cites USEPA concerns.","Growth across all three segments (US Crop, US Non-crop, International); destocking subsiding but channel remains cautious."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-136157","json":"https://secwatch.observer/filing/0001193125-24-136157.json","markdown":"https://secwatch.observer/filing/0001193125-24-136157.md","text":"https://secwatch.observer/filing/0001193125-24-136157.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/5981/000119312524136157/0001193125-24-136157-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/5981/000119312524136157/d770184d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:21:24.934178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90089b87e708f4e3e94ba15674888d3e6b071b5d","claim":"AMERICAN VANGUARD CORP reported the first quarter ended March 31, 2024 results: revenue $135 million, net income $1.6 million, EPS $0.06. Guidance reaffirmed.","evidence_excerpt":"(NYSE: AVD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights – versus First Quarter 2023: • Net sales of $135 million vs. $125 million • Adjusted EBITDA 1 of $15.5 million vs. $11.5 million • Operating Income of $6.1 million vs. $3.3 million • Net income of $1.6 million vs. $1.9 million •","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/5981/000119312524136157/0001193125-24-136157-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$135 million"},{"label":"Net income","value":"$1.6 million"},{"label":"EPS","value":"$0.06"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}